Pre-Test - Advances in DMTs
Please choose the best answer for the question below then click the button at the bottom to proceed.
Which of the following pairs correctly matches an investigational disease-modifying therapy with its therapeutic target?
*
Evobrutinib; sphingosine-1 phosphate receptor
Ofatumumab; CD52
Opicinumab; CD20
Temelimab; human endogenous retrovirus
This iframe contains the logic required to handle Ajax powered Gravity Forms.
